ReviewInvestigational new drugs2022

CD25-targeted antibody-drug conjugate camidanlumab tesirine for relapsed or refractory classical Hodgkin lymphoma.

Bo Xu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.